The role of serotonin in memory: interactions with neurotransmitters and downstream signaling

Experimental Brain Research

Volumn 232, Issue 3, 2014, Pages 723-738

  Seyedabadi, Mohammad ^a   Fakhfouri, Gohar ^b,c   Ramezani, Vahid ^d   Mehr, Shahram Ejtemaei ^e   Rahimian, Reza ^e  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITÉ LAVAL   (Canada)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^d SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Memory; Serotonin; Signaling pathways

Indexed keywords

NEUROTRANSMITTER; SEROTONIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CHOLINERGIC ACTIVITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; GABAERGIC TRANSMISSION; GLUTAMATERGIC SYNAPSE; HUMAN; INTRACELLULAR SIGNALING; MEMORY; NEUROMODULATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MEMORY; NEUROTRANSMITTER AGENTS; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84907798525     PISSN: 00144819     EISSN: 14321106     Source Type: Journal    
DOI: 10.1007/s00221-013-3818-4     Document Type: Review

References (177)

1. Acosta JI, Boynton FA, Kirschner KF, Neisewander JL (2005) Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior. Pharmacol Biochem Behav 80:297–307. doi:10.1016/j.pbb.2004.12.001
2. Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296–320. doi:10.1016/j.pharmthera.2006.08.004
3. Altman HJ, Stone WS, Ogren SO (1987) Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval. Behav Neural Biol 48:49–62
4. Andrews CM, Kung HF, Lucki I (2005) The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. Eur J Pharmacol 508:123–130. doi:10.1016/j.ejphar.2004.12.033
5. Angers A, Fioravante D, Chin J, Cleary LJ, Bean AJ (2002) Byrne JH (2002) Serotonin stimulates phosphorylation of Aplysia synapsin and alters its subcellular distribution in sensory neurons. J Neurosci 22:5412–5422.
6. Arjona AA, Pooler AM, Lee RK, Wurtman RJ (2002) Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs. Brain Res 951:135–140
7. Aznar S, Qian Z, Shah R, Rahbek B, Knudsen GM (2003) The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 959:58–67
8. Barbas D, DesGroseillers L, Castellucci VF, Carew TJ, Marinesco S (2003) Multiple serotonergic mechanisms contributing to sensitization in Aplysia: evidence of diverse serotonin receptor subtypes. Learn Mem 10:373–386. doi:10.1101/lm.66103
9. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152
10. Bernedo V, Insua D, Suarez ML, Santamarina G, Sarasa M, Pesini P (2009) Beta-amyloid cortical deposits are accompanied by the loss of serotonergic neurons in the dog. J Comp Neurol 513:417–429. doi:10.1002/cne.21985
11. Bevilaqua L, Ardenghi P, Schroder N et al (1997) Drugs acting upon the cyclic adenosine monophosphate/protein kinase A signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala. Behav Pharmacol 8:331–338
12. Bisaga A, Sikora J, Kostowski W (1993) The effect of drugs interacting with serotonergic 5HT3 and 5HT4 receptors on morphine place conditioning. Pol J Pharmacol 45:513–519
13. Blokland A, Schreiber R, Prickaerts J (2006) Improving memory: a role for phosphodiesterases. Curr Pharm Des 12:2511–2523
14. Boess FG, de Vry J, Erb C et al (2013) Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel alpha7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist. Psychopharmacology 227:1–17. doi:10.1007/s00213-012-2933-4
15. Bombardi C, Di Giovanni G (2013) Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions. Exp Brain Res 230:427–439. doi:10.1007/s00221-013-3512-6
16. Bonaventure P, Aluisio L, Shoblock J et al (2011) Pharmacological blockade of serotonin 5-HT(7) receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission. PLoS One 6:e20210. doi:10.1371/journal.pone.0020210
17. Boulougouris V, Tsaltas E (2008) Serotonergic and dopaminergic modulation of attentional processes. Prog Brain Res 172:517–542. doi:10.1016/S0079-6123(08)00925-4
18. Brambilla A, Ghiorzi A, Pitsikas N, Borsini F (1993) DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats. J Pharm Pharmacol 45:841–843
19. Broocks A, Little JT, Martin A et al (1998) The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. Biol Psychiatry 43:408–416
20. Burmeister JJ, Lungren EM, Kirschner KF, Neisewander JL (2004) Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29:660–668. doi:10.1038/sj.npp.1300346
21. Byrne JH, Kandel ER (1996) Presynaptic facilitation revisited: state and time dependence. J Neurosci 16:425–435
22. Cai D, Pearce K, Chen S, Glanzman DL (2011) Protein kinase M maintains long-term sensitization and long-term facilitation in Aplysia. J Neurosci 31:6421–6431. doi:10.1523/JNEUROSCI.4744-10.2011
23. Cammarota M, Bevilaqua LR, Medina JH, Izquierdo I (2008) ERK1/2 and CaMKII-mediated events in memory formation: is 5HT regulation involved? Behav Brain Res 195:120–128. doi:10.1016/j.bbr.2007.11.029
24. Campbell AD, McBride WJ (1995) Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol Biochem Behav 51:835–842
25. Carboni E, Acquas E, Leone P, Di Chiara G (1989) 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 97:175–178
26. Carey RJ, Depalma G, Damianopoulos E, Muller CP, Huston JP (2004) The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology 177:46–54. doi:10.1007/s00213-004-1917-4
27. Carli M, Bonalumi P, Samanin R (1997a) WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 774:167–174
28. Carli M, Luschi R, Samanin R (1997b) Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist. Behav Brain Res 82:185–194
29. Carli M, Bonalumi P, Samanin R (1998) Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats. Eur J Neurosci 10:221–230
30. Carli M, Silva S, Balducci C, Samanin R (1999) WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 38:1165–1173
31. Carli M, Balducci C, Samanin R (2000) Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe. Br J Pharmacol 131:375–381. doi:10.1038/sj.bjp.0703567
32. Carli M, Balducci C, Samanin R (2001) Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats. Psychopharmacology 158:39–47. doi:10.1007/s002130100837
33. Carlini VP, Poretti MB, Rask-Andersen M et al (2012) Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action. Prog Neuropsychopharmacol Biol Psychiatry 38:159–167. doi:10.1016/j.pnpbp.2012.03.004
34. Cervo L, Rozio M, Ekalle-Soppo CB, Carnovali F, Santangelo E, Samanin R (2002) Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats. Psychopharmacology 163:142–150. doi:10.1007/s00213-002-1145-8
35. Chen J, Paredes W, Van Praag HM, Lowinson JH, Gardner EL (1992) Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10:264–266. doi:10.1002/syn.890100308
36. Cho S, Hu Y (2007) Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival. Exp Neurol 203:274–278. doi:10.1016/j.expneurol.2006.07.021
37. Chugh Y, Saha N, Sankaranarayanan A, Datta H (1991) Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930. Pharmacol Toxicol 69:105–106
38. Cirrito JR, Disabato BM, Restivo JL et al (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108:14968–14973. doi:10.1073/pnas.1107411108
39. Consolo S, Arnaboldi S, Giorgi S, Russi G, Ladinsky H (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 5:1230–1232
40. Costa L, Spatuzza M, D’Antoni S et al (2012) Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. Biol Psychiatry 72:924–933. doi:10.1016/j.biopsych.2012.06.008
41. Da Silva Costa-Aze V, Quiedeville A, Boulouard M, Dauphin F (2012) 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice. Psychopharmacology 222:99–115. doi:10.1007/s00213-011-2627-3
42. Dawson LA, Nguyen HQ, Li P (2001) The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662–668. doi:10.1016/S0893-133X(01)00265-2
43. De Deurwaerdere P, Moison D, Navailles S, Porras G, Spampinato U (2005) Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens. J Neurochem 94:140–149. doi:10.1111/j.1471-4159.2005.03174.x
44. Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587–597
45. Di Giovanni G, Di Matteo V, La Grutta V, Esposito E (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111–116
46. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195–1205
47. Diaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F (2005) Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci 25:10831–10843. doi:10.1523/JNEUROSCI.2999-05.2005
48. Elvander-Tottie E, Eriksson TM, Sandin J, Ogren SO (2009) 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning. Hippocampus 19:1187–1198. doi:10.1002/hipo.20596
49. Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO (2008) Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology 54:1041–1050. doi:10.1016/j.neuropharm.2008.02.007
50. Eriksson TM, Delagrange P, Spedding M, Popoli M, Mathe AA, Ogren SO, Svenningsson P (2012) Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry 17:173–184. doi:10.1038/mp.2010.131
51. Eriksson TM, Alvarsson A, Stan TL et al (2013) Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Mol Psychiatry 18:1096–1105. doi:10.1038/mp.2012.130
52. Fakhfouri G, Rahimian R, Ghia JE, Khan WI, Dehpour AR (2012) Impact of 5-HT(3) receptor antagonists on peripheral and central diseases. Drug Discov Today 17:741–747. doi:10.1016/j.drudis.2012.02.009
53. Ferguson SM, Mitchell ES, Neumaier JF (2008) Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol Psychiatry 63:207–213. doi:10.1016/j.biopsych.2007.02.018
54. Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306:734–743. doi:10.1124/jpet.102.045716
55. Fletcher PJ, Chintoh AF, Sinyard J, Higgins GA (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308–318. doi:10.1038/sj.npp.1300319
56. Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA (2008) The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33:1402–1412. doi:10.1038/sj.npp.1301509
57. Foley AG, Murphy KJ, Hirst WD et al (2004) The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29:93–100. doi:10.1038/sj.npp.1300332
58. Frantz KJ, Hansson KJ, Stouffer DG, Parsons LH (2002) 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology 42:170–180
59. Geldenhuys WJ, Van der Schyf CJ (2009) The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease. Expert Rev Neurother 9:1073–1085. doi:10.1586/ern.09.51
60. Goldsmith BA, Abrams TW (1992) cAMP modulates multiple K+ currents, increasing spike duration and excitability in Aplysia sensory neurons. Proc Natl Acad Sci U S A 89:11481–11485
61. Grant KA, Barrett JE (1991) Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists. Psychopharmacology 104:451–456
62. Harkany T, Dijkstra IM, Oosterink BJ et al (2000) Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 101:101–114
63. Harkany T, Mulder J, Horvath KM, Keijser J, van der Meeberg EK, Nyakas C, Luiten PG (2001) Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis. Neuroscience 108:629–642
64. Hart AK, Fioravante D, Liu RY, Phares GA, Cleary LJ, Byrne JH (2011) Serotonin-mediated synapsin expression is necessary for long-term facilitation of the Aplysia sensorimotor synapse. J Neurosci 31:18401–18411. doi:10.1523/JNEUROSCI.2816-11.2011
65. Hensler JG (2002) Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26:565–573. doi:10.1016/S0893-133X(01)00395-5
66. Herrmann AP, Lunardi P, Pilz LK et al (2012) Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices. Neurochem Int 61:1144–1150. doi:10.1016/j.neuint.2012.08.006
67. Hilgert M, Buchholzer M, Jeltsch H, Kelche C, Cassel JC, Klein J (2000) Serotonergic modulation of hippocampal acetylcholine release after long-term neuronal grafting. NeuroReport 11:3063–3065
68. Hodges H, Sowinski P, Sinden JD, Netto CA, Fletcher A (1995) The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. Psychopharmacology 117:318–332
69. Horiguchi M, Huang M, Meltzer HY (2011a) Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Psychopharmacology 217:13–24. doi:10.1007/s00213-011-2251-2
70. Horiguchi M, Huang M, Meltzer HY (2011b) The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exp Ther 338:605–614. doi:10.1124/jpet.111.180638
71. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554
72. Hu JY, Baussi O, Levine A, Chen Y, Schacher S (2011) Persistent long-term synaptic plasticity requires activation of a new signaling pathway by additional stimuli. J Neurosci 31:8841–8850. doi:10.1523/JNEUROSCI.1358-11.2011
73. Huang YY, Kandel ER (2007) 5-Hydroxytryptamine induces a protein kinase A/mitogen-activated protein kinase-mediated and macromolecular synthesis-dependent late phase of long-term potentiation in the amygdala. J Neurosci 27:3111–3119. doi:10.1523/JNEUROSCI.3908-06.2007
74. Imperato A, Angelucci L (1989) 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci Lett 101:214–217
75. Jiang LH, Ashby CR Jr, Kasser RJ, Wang RY (1990) The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res 513:156–160
76. Johnson BA, Ait-Daoud N, Elkashef AM et al (2008a) A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. Int J Neuropsychopharmacol 11:1–14. doi:10.1017/S1461145707007778
77. Johnson CN, Ahmed M, Miller ND (2008b) 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia. Curr Opin Drug Discov Devel 11:642–654
78. Ju Yeon B, Yeon Hee S (2005) Blockade of 5-HT(3) receptor with MDL 72222 and Y 25130 reduces beta-amyloid protein (25–35)-induced neurotoxicity in cultured rat cortical neurons. Eur J Pharmacol 520:12–21. doi:10.1016/j.ejphar.2005.07.021
79. Kagami Y, Shigenobu S, Watanabe S (1992) Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices. Eur J Pharmacol 224:51–56
80. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75–113
81. Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378–387
82. Kenakin T (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232–238
83. Kendall I, Slotten HA, Codony X, Burgueno J, Pauwels PJ, Vela JM, Fone KC (2011) E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology 213:413–430. doi:10.1007/s00213-010-1854-3
84. Kia HK, Brisorgueil MJ, Daval G, Langlois X, Hamon M, Verge D (1996) Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca–a double immunocytochemical study. Neuroscience 74:143–154
85. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation–an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195–204. doi:10.1016/j.neuropharm.2004.03.012
86. Kiser D, Steemers B, Branchi I, Homberg JR (2012) The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev 36:786–798. doi:10.1016/j.neubiorev.2011.12.009
87. Koenig J, Lecourtier L, Cosquer B, Pereira PM, Cassel JC (2011) Spatial memory alterations by activation of septal 5HT 1A receptors: no implication of cholinergic septohippocampal neurons. Psychopharmacology 214:437–454. doi:10.1007/s00213-010-2049-7
88. Kranz GS, Kasper S, Lanzenberger R (2010) Reward and the serotonergic system. Neuroscience 166:1023–1035. doi:10.1016/j.neuroscience.2010.01.036
89. Lee YS, Choi SL, Lee SH et al (2009) Identification of a serotonin receptor coupled to adenylyl cyclase involved in learning-related heterosynaptic facilitation in Aplysia. Proc Natl Acad Sci U S A 106:14634–14639. doi:10.1073/pnas.0907502106
90. Lelong V, Lhonneur L, Dauphin F, Boulouard M (2003) BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn Schmiedebergs Arch Pharmacol 367:621–628. doi:10.1007/s00210-003-0743-2
91. Lesch KP, Waider J (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76:175–191. doi:10.1016/j.neuron.2012.09.013
92. Levallet G, Hotte M, Boulouard M, Dauphin F (2009) Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat. Psychopharmacology 202:125–139. doi:10.1007/s00213-008-1283-8
93. Lezoualc’h F (2007) 5-HT4 receptor and Alzheimer’s disease: the amyloid connection. Exp Neurol 205:325–329. doi:10.1016/j.expneurol.2007.02.001
94. Li Q, Muma NA, Battaglia G, Van de Kar LD (1997) A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J Pharmacol Exp Ther 282:1581–1590
95. Llado-Pelfort L, Santana N, Ghisi V, Artigas F, Celada P (2012) 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb Cortex 22:1487–1497. doi:10.1093/cercor/bhr220
96. Madsen K, Neumann WJ, Holst K et al (2011) Cerebral serotonin 4 receptors and amyloid-beta in early Alzheimer’s disease. J Alzheimers Dis 26:457–466. doi:10.3233/JAD-2011-110056
97. Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L (2006) Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70:1013–1021. doi:10.1124/mol.106.022756
98. Manuel-Apolinar L, Meneses A (2004) 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behav Brain Res 148:179–184
99. Marcos B, Gil-Bea FJ, Hirst WD, Garcia-Alloza M, Ramirez MJ (2006) Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24:1299–1306. doi:10.1111/j.1460-9568.2006.05003.x
100. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254:432–437
101. Marsden CA, King MV, Fone KC (2011) Influence of social isolation in the rat on serotonergic function and memory–relevance to models of schizophrenia and the role of 5-HT(6) receptors. Neuropharmacology 61:400–407. doi:10.1016/j.neuropharm.2011.03.003
102. Martin KC, Michael D, Rose JC, Barad M, Casadio A, Zhu H, Kandel ER (1997) MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18:899–912
103. Matsumoto M, Togashi H, Mori K, Ueno K, Ohashi S, Kojima T, Yoshioka M (2001) Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther 296:676–682
104. Matsuno K, Senda T, Matsunaga K, Mita S, Kaneto H (1993) Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Psychopharmacology 112:134–141
105. McLean JH, Smith A, Rogers S, Clarke K, Darby-King A, Harley CW (2009) A phosphodiesterase inhibitor, cilomilast, enhances cAMP activity to restore conditioned odor preference memory after serotonergic depletion in the neonate rat. Neurobiol Learn Mem 92:63–69. doi:10.1016/j.nlm.2009.02.003
106. McMahon LR, Cunningham KA (1999) Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell. J Pharmacol Exp Ther 291:300–307
107. Meltzer HY, Massey BW, Horiguchi M (2012) Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. Curr Pharm Biotechnol 13:1572–1586
108. Meneses A (2004) Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav Brain Res 155:275–282. doi:10.1016/j.bbr.2004.04.026
109. Misane I, Ogren SO (2003) Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat. Neuropsychopharmacology 28:253–264. doi:10.1038/sj.npp.1300024
110. Mitchell ES, Neumaier JF (2005) 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108:320–333. doi:10.1016/j.pharmthera.2005.05.001
111. Morales M, Wang SD, Diaz-Ruiz O, Jho DH (2004) Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon. J Comp Neurol 468:205–216. doi:10.1002/cne.10968
112. Mori K, Togashi H, Kojima T, Matsumoto M, Ohashi S, Ueno K, Yoshioka M (2001) Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo. Pharmacol Biochem Behav 69:367–372
113. Moser PC, Bergis OE, Jegham S et al (2002) SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther 302:731–741. doi:10.1124/jpet.102.034249
114. Navailles S, De Deurwaerdere P, Porras G, Spampinato U (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29:319–326. doi:10.1038/sj.npp.1300329
115. Neisewander JL, Acosta JI (2007) Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18:791–800. doi:10.1097/FBP.0b013e3282f1c94b
116. Nic Dhonnchadha BA, Cunningham KA (2008) Serotonergic mechanisms in addiction-related memories. Behav Brain Res 195:39–53. doi:10.1016/j.bbr.2008.06.026
117. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (2009) Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123:382–396. doi:10.1037/a0014592
118. Nitsch RM, Deng M, Growdon JH, Wurtman RJ (1996) Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 271:4188–4194
119. Noristani HN, Verkhratsky A, Rodriguez JJ (2012) High tryptophan diet reduces CA1 intraneuronal beta-amyloid in the triple transgenic mouse model of Alzheimer’s disease. Aging Cell 11:810–822. doi:10.1111/j.1474-9726.2012.00845.x
120. O’Dell LE, Parsons LH (2004) Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. J Pharmacol Exp Ther 311:711–719. doi:10.1124/jpet.104.069278
121. Ohno M, Watanabe S (1996) Blockade of 5-HT1A receptors compensates loss of hippocampal cholinergic neurotransmission involved in working memory of rats. Brain Res 736:180–188
122. Ohno M, Watanabe S (1997) Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats. Brain Res 762:211–215
123. Pakaski M, Bjelik A, Hugyecz M, Kasa P, Janka Z, Kalman J (2005) Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro. Neurochem Int 47:190–195. doi:10.1016/j.neuint.2005.03.004
124. Pandya AA, Yakel JL (2013) Activation of the alpha7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT(1)a receptor antagonist. Neuropharmacology 70:35–42. doi:10.1016/j.neuropharm.2013.01.004
125. Paris JM, Cunningham KA (1991) Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology 104:475–478
126. Park SM, Williams CL (2012) Contribution of serotonin type 3 receptors in the successful extinction of cued or contextual fear conditioned responses: interactions with GABAergic signaling. Rev Neurosci 23:555–569. doi:10.1515/revneuro-2012-0052
127. Parsons LH, Weiss F, Koob GF (1998) Serotonin1B receptor stimulation enhances cocaine reinforcement. J Neurosci 18:10078–10089
128. Payton S, Cahill CM, Randall JD, Gullans SR, Rogers JT (2003) Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region: the action of paroxetine and dimercaptopropanol. J Mol Neurosci 20:267–275. doi:10.1385/jmn:20:3:267
129. Pei Q, Zetterstrom T, Leslie RA, Grahame-Smith DG (1993) 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur J Pharmacol 230:63–68
130. Perez-Garcia GS, Meneses A (2005) Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behav Brain Res 163:136–140. doi:10.1016/j.bbr.2005.04.014
131. Perez-Garcia G, Meneses A (2008a) Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia. Behav Brain Res 195:139–146. doi:10.1016/j.bbr.2008.07.033
132. Perez-Garcia G, Meneses A (2008b) Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role. Behav Brain Res 195:17–29. doi:10.1016/j.bbr.2007.11.027
133. Pitsikas N, Rigamonti AE, Cella SG, Muller EE (2003) The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Brain Res 983:215–222
134. Pitsikas N, Zisopoulou S, Pappas I, Sakellaridis N (2008) The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. Behav Brain Res 188:304–309. doi:10.1016/j.bbr.2007.11.010
135. Polter AM, Li X (2010) 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 22:1406–1412. doi:10.1016/j.cellsig.2010.03.019
136. Porras G, Di Matteo V, De Deurwaerdere P, Esposito E, Spampinato U (2002) Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology 43:1099–1109
137. Postina R (2012) Activation of alpha-secretase cleavage. J Neurochem 120(Suppl 1):46–54. doi:10.1111/j.1471-4159.2011.07459.x
138. Price TL, Darby-King A, Harley CW, McLean JH (1998) Serotonin plays a permissive role in conditioned olfactory learning induced by norepinephrine in the neonate rat. Behav Neurosci 112:1430–1437
139. Pytliak M, Vargova V, Mechirova V, Felsoci M (2011) Serotonin receptors - from molecular biology to clinical applications. Physiol Res 60:15–25
140. Raap DK, Evans S, Garcia F et al (1999) Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther 288:98–106
141. Rahimian R, Fakhfouri G, Ejtemaei Mehr S et al (2013) Tropisetron attenuates amyloid-beta-induced inflammatory and apoptotic responses in rats. Eur J Clin Invest 43:1039–1051. doi:10.1111/eci.12141
142. Richter-Levin G, Segal M (1989) Raphe cells grafted into the hippocampus can ameliorate spatial memory deficits in rats with combined serotonergic/cholinergic deficiencies. Brain Res 478:184–186
143. Robert SJ, Zugaza JL, Fischmeister R, Gardier AM, Lezoualc’h F (2001) The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J Biol Chem 276:44881–44888. doi:10.1074/jbc.M109008200
144. Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc’h F (2005) Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac. FEBS Lett 579:1136–1142. doi:10.1016/j.febslet.2005.01.010
145. Rodd-Henricks ZA, McKinzie DL, Melendez RI, Berry N, Murphy JM, McBride WJ (2003) Effects of serotonin-3 receptor antagonists on the intracranial self-administration of ethanol within the ventral tegmental area of Wistar rats. Psychopharmacology 165:252–259. doi:10.1007/s00213-002-1300-2
146. Rodriguez JJ, Noristani HN, Verkhratsky A (2012) The serotonergic system in ageing and Alzheimer’s disease. Prog Neurobiol 99:15–41. doi:10.1016/j.pneurobio.2012.06.010
147. Rozas C, Loyola S, Ugarte G et al (2012) Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism. Eur Neuropsychopharmacol 22:584–595. doi:10.1016/j.euroneuro.2011.11.010
148. Rutten K, Lieben C, Smits L, Blokland A (2007a) The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology 192:275–282. doi:10.1007/s00213-006-0697-4
149. Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A (2007b) Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol 558:107–112. doi:10.1016/j.ejphar.2006.11.041
150. Sacktor TC, Kruger KE, Schwartz JH (1988) Activation of protein kinase C by serotonin: biochemical evidence that it participates in the mechanisms underlying facilitation in Aplysia. J Physiol (Paris) 83:224–231
151. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100–1109. doi:10.1093/cercor/bhh070
152. Santana N, Mengod G, Artigas F (2009) Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 19:849–860. doi:10.1093/cercor/bhn134
153. Schiapparelli L, Del Rio J, Frechilla D (2005) Serotonin 5-HT receptor blockade enhances Ca(2+)/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation. J Neurochem 94:884–895. doi:10.1111/j.1471-4159.2005.03193.x
154. Schilstrom B, Konradsson-Geuken A, Ivanov V et al (2011) Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-d-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat. Synapse 65:357–367. doi:10.1002/syn.20853
155. Segu L, Lecomte MJ, Wolff M et al (2010) Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice. PLoS ONE 5:e9529. doi:10.1371/journal.pone.0009529
156. Siniscalchi A, Badini I, Beani L, Bianchi C (1999) 5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices. NeuroReport 10:547–551
157. Soria-Fregozo C, Flores-Soto ME, Perez-Vega MI, Feria-Velasco A (2013) 5-HT denervation of the adult rat prefrontal cortex induces changes in the expression of alpha4 and alpha7 nicotinic acetylcholine receptor subtypes. Neurologia 28:212–218. doi:10.1016/j.nrl.2012.04.002
158. Staubli U, Xu FB (1995) Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 15:2445–2452
159. Takumi Y, Bergersen L, Landsend AS, Rinvik E, Ottersen OP (1998) Synaptic arrangement of glutamate receptors. Prog Brain Res 116:105–121
160. Terry AV Jr, Buccafusco JJ, Prendergast MA et al (1996) The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. NeuroReport 8:49–54
161. Tottori K, Nakai M, Uwahodo Y et al (2002) Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quino linone monomethanesulfonate). J Pharmacol Exp Ther 301:249–257
162. Toyohara J, Hashimoto K (2010) alpha7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease. Open Med Chem J 4:37–56. doi:10.2174/1874104501004010037
163. Upadhya SC, Smith TK, Hegde AN (2004) Ubiquitin-proteasome-mediated CREB repressor degradation during induction of long-term facilitation. J Neurochem 91:210–219. doi:10.1111/j.1471-4159.2004.02707.x
164. Upton N, Chuang TT, Hunter AJ, Virley DJ (2008) 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease. Neurotherapeutics 5:458–469. doi:10.1016/j.nurt.2008.05.008
165. Valentini V, Piras G, De Luca MA et al (2013) Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. Neuropharmacology 65:58–64. doi:10.1016/j.neuropharm.2012.08.025
166. van Donkelaar EL, Rutten K, Blokland A, Akkerman S, Steinbusch HW, Prickaerts J (2008) Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion. Eur J Pharmacol 600:98–104. doi:10.1016/j.ejphar.2008.10.027
167. van Gaalen MM, Schetters D, Schoffelmeer AN, De Vries TJ (2010) 5-HT6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement. Int J Neuropsychopharmacol 13:961–965. doi:10.1017/S1461145710000428
168. Verdurand M, Berod A, Le Bars D, Zimmer L (2011) Effects of amyloid-beta peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus. Neurobiol Aging 32:103–114. doi:10.1016/j.neurobiolaging.2009.01.008
169. Waider J, Proft F, Langlhofer G, Asan E, Lesch KP, Gutknecht L (2013) GABA concentration and GABAergic neuron populations in limbic areas are differentially altered by brain serotonin deficiency in Tph2 knockout mice. Histochem Cell Biol 139:267–281. doi:10.1007/s00418-012-1029-x
170. Wang RY, Arvanov VL (1998) M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res 779:309–313
171. West PJ, Marcy VR, Marino MJ, Schaffhauser H (2009) Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience 164:692–701. doi:10.1016/j.neuroscience.2009.07.061
172. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225. doi:10.1146/annurev.ps.40.020189.001203
173. Woods S, Clarke NN, Layfield R, Fone KC (2012) 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. Br J Pharmacol 167:436–449. doi:10.1111/j.1476-5381.2012.02022.x
174. Woolley ML, Marsden CA, Sleight AJ, Fone KC (2003) Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology 170:358–367. doi:10.1007/s00213-003-1552-5
175. Woolley ML, Marsden CA, Fone KC (2004) 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 3:59–79
176. Yuan Q, Harley CW, Bruce JC, Darby-King A, McLean JH (2000) Isoproterenol increases CREB phosphorylation and olfactory nerve-evoked potentials in normal and 5-HT-depleted olfactory bulbs in rat pups only at doses that produce odor preference learning. Learn Mem 7:413–421
177. Yuan Q, Harley CW, McLean JH (2003) Mitral cell beta1 and 5-HT2A receptor colocalization and cAMP coregulation: a new model of norepinephrine-induced learning in the olfactory bulb. Learn Mem 10:5–15. doi:10.1101/lm.54803